The global Urea Cycle Disorders Treatment Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Urea Cycle Disorders Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urea Cycle Disorders Treatment Drug.

Report Scope

The Urea Cycle Disorders Treatment Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Urea Cycle Disorders Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Urea Cycle Disorders Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Urea Cycle Disorders Treatment Drug Market Report

Report Metric	Details
Report Name	Urea Cycle Disorders Treatment Drug Market
CAGR	5%
Segment by Type	Amino Acid Supplements Sodium Phenylbutyrate Glycerol Phenylbutyrate Sodium Benzoate Others
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Horizon Therapeutics Plc, Bausch Health Companies Inc., Recordati Rare Diseases Inc., Nestle S.A., Danone S.A., Lucane Pharma SA, Acer Therapeutics Inc., Ultragenyx Pharmaceutical, Aeglea Biotherapeutics, Inc, Arcturus Therapeutics Holdings Inc., Orpharma Pty Ltd., Selecta Biosciences, Inc., Abbott, Mead Johnson & Company, LLC
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Urea Cycle Disorders Treatment Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Urea Cycle Disorders Treatment Drug Market report?

Ans: The main players in the Urea Cycle Disorders Treatment Drug Market are Horizon Therapeutics Plc, Bausch Health Companies Inc., Recordati Rare Diseases Inc., Nestle S.A., Danone S.A., Lucane Pharma SA, Acer Therapeutics Inc., Ultragenyx Pharmaceutical, Aeglea Biotherapeutics, Inc, Arcturus Therapeutics Holdings Inc., Orpharma Pty Ltd., Selecta Biosciences, Inc., Abbott, Mead Johnson & Company, LLC

What are the Application segmentation covered in the Urea Cycle Disorders Treatment Drug Market report?

Ans: The Applications covered in the Urea Cycle Disorders Treatment Drug Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Urea Cycle Disorders Treatment Drug Market report?

Ans: The Types covered in the Urea Cycle Disorders Treatment Drug Market report are Amino Acid Supplements, Sodium Phenylbutyrate, Glycerol Phenylbutyrate, Sodium Benzoate, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Amino Acid Supplements

1.2.3 Sodium Phenylbutyrate

1.2.4 Glycerol Phenylbutyrate

1.2.5 Sodium Benzoate

1.2.6 Others

1.3 Market by Application

1.3.1 Global Urea Cycle Disorders Treatment Drug Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Urea Cycle Disorders Treatment Drug Market Perspective (2019-2030)

2.2 Urea Cycle Disorders Treatment Drug Growth Trends by Region

2.2.1 Global Urea Cycle Disorders Treatment Drug Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Urea Cycle Disorders Treatment Drug Historic Market Size by Region (2019-2024)

2.2.3 Urea Cycle Disorders Treatment Drug Forecasted Market Size by Region (2025-2030)

2.3 Urea Cycle Disorders Treatment Drug Market Dynamics

2.3.1 Urea Cycle Disorders Treatment Drug Industry Trends

2.3.2 Urea Cycle Disorders Treatment Drug Market Drivers

2.3.3 Urea Cycle Disorders Treatment Drug Market Challenges

2.3.4 Urea Cycle Disorders Treatment Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Urea Cycle Disorders Treatment Drug Players by Revenue

3.1.1 Global Top Urea Cycle Disorders Treatment Drug Players by Revenue (2019-2024)

3.1.2 Global Urea Cycle Disorders Treatment Drug Revenue Market Share by Players (2019-2024)

3.2 Global Urea Cycle Disorders Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Urea Cycle Disorders Treatment Drug Revenue

3.4 Global Urea Cycle Disorders Treatment Drug Market Concentration Ratio

3.4.1 Global Urea Cycle Disorders Treatment Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Urea Cycle Disorders Treatment Drug Revenue in 2023

3.5 Urea Cycle Disorders Treatment Drug Key Players Head office and Area Served

3.6 Key Players Urea Cycle Disorders Treatment Drug Product Solution and Service

3.7 Date of Enter into Urea Cycle Disorders Treatment Drug Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Urea Cycle Disorders Treatment Drug Breakdown Data by Type

4.1 Global Urea Cycle Disorders Treatment Drug Historic Market Size by Type (2019-2024)

4.2 Global Urea Cycle Disorders Treatment Drug Forecasted Market Size by Type (2025-2030)

5 Urea Cycle Disorders Treatment Drug Breakdown Data by Application

5.1 Global Urea Cycle Disorders Treatment Drug Historic Market Size by Application (2019-2024)

5.2 Global Urea Cycle Disorders Treatment Drug Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Urea Cycle Disorders Treatment Drug Market Size (2019-2030)

6.2 North America Urea Cycle Disorders Treatment Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Urea Cycle Disorders Treatment Drug Market Size by Country (2019-2024)

6.4 North America Urea Cycle Disorders Treatment Drug Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Urea Cycle Disorders Treatment Drug Market Size (2019-2030)

7.2 Europe Urea Cycle Disorders Treatment Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Urea Cycle Disorders Treatment Drug Market Size by Country (2019-2024)

7.4 Europe Urea Cycle Disorders Treatment Drug Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size (2019-2030)

8.2 Asia-Pacific Urea Cycle Disorders Treatment Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size by Region (2019-2024)

8.4 Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Urea Cycle Disorders Treatment Drug Market Size (2019-2030)

9.2 Latin America Urea Cycle Disorders Treatment Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Urea Cycle Disorders Treatment Drug Market Size by Country (2019-2024)

9.4 Latin America Urea Cycle Disorders Treatment Drug Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size (2019-2030)

10.2 Middle East & Africa Urea Cycle Disorders Treatment Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size by Country (2019-2024)

10.4 Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Horizon Therapeutics Plc

11.1.1 Horizon Therapeutics Plc Company Detail

11.1.2 Horizon Therapeutics Plc Business Overview

11.1.3 Horizon Therapeutics Plc Urea Cycle Disorders Treatment Drug Introduction

11.1.4 Horizon Therapeutics Plc Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024)

11.1.5 Horizon Therapeutics Plc Recent Development

11.2 Bausch Health Companies Inc.

11.2.1 Bausch Health Companies Inc. Company Detail

11.2.2 Bausch Health Companies Inc. Business Overview

11.2.3 Bausch Health Companies Inc. Urea Cycle Disorders Treatment Drug Introduction

11.2.4 Bausch Health Companies Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024)

11.2.5 Bausch Health Companies Inc. Recent Development

11.3 Recordati Rare Diseases Inc.

11.3.1 Recordati Rare Diseases Inc. Company Detail

11.3.2 Recordati Rare Diseases Inc. Business Overview

11.3.3 Recordati Rare Diseases Inc. Urea Cycle Disorders Treatment Drug Introduction

11.3.4 Recordati Rare Diseases Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024)

11.3.5 Recordati Rare Diseases Inc. Recent Development

11.4 Nestle S.A.

11.4.1 Nestle S.A. Company Detail

11.4.2 Nestle S.A. Business Overview

11.4.3 Nestle S.A. Urea Cycle Disorders Treatment Drug Introduction

11.4.4 Nestle S.A. Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024)

11.4.5 Nestle S.A. Recent Development

11.5 Danone S.A.

11.5.1 Danone S.A. Company Detail

11.5.2 Danone S.A. Business Overview

11.5.3 Danone S.A. Urea Cycle Disorders Treatment Drug Introduction

11.5.4 Danone S.A. Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024)

11.5.5 Danone S.A. Recent Development

11.6 Lucane Pharma SA

11.6.1 Lucane Pharma SA Company Detail

11.6.2 Lucane Pharma SA Business Overview

11.6.3 Lucane Pharma SA Urea Cycle Disorders Treatment Drug Introduction

11.6.4 Lucane Pharma SA Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024)

11.6.5 Lucane Pharma SA Recent Development

11.7 Acer Therapeutics Inc.

11.7.1 Acer Therapeutics Inc. Company Detail

11.7.2 Acer Therapeutics Inc. Business Overview

11.7.3 Acer Therapeutics Inc. Urea Cycle Disorders Treatment Drug Introduction

11.7.4 Acer Therapeutics Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024)

11.7.5 Acer Therapeutics Inc. Recent Development

11.8 Ultragenyx Pharmaceutical

11.8.1 Ultragenyx Pharmaceutical Company Detail

11.8.2 Ultragenyx Pharmaceutical Business Overview

11.8.3 Ultragenyx Pharmaceutical Urea Cycle Disorders Treatment Drug Introduction

11.8.4 Ultragenyx Pharmaceutical Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024)

11.8.5 Ultragenyx Pharmaceutical Recent Development

11.9 Aeglea Biotherapeutics, Inc

11.9.1 Aeglea Biotherapeutics, Inc Company Detail

11.9.2 Aeglea Biotherapeutics, Inc Business Overview

11.9.3 Aeglea Biotherapeutics, Inc Urea Cycle Disorders Treatment Drug Introduction

11.9.4 Aeglea Biotherapeutics, Inc Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024)

11.9.5 Aeglea Biotherapeutics, Inc Recent Development

11.10 Arcturus Therapeutics Holdings Inc.

11.10.1 Arcturus Therapeutics Holdings Inc. Company Detail

11.10.2 Arcturus Therapeutics Holdings Inc. Business Overview

11.10.3 Arcturus Therapeutics Holdings Inc. Urea Cycle Disorders Treatment Drug Introduction

11.10.4 Arcturus Therapeutics Holdings Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024)

11.10.5 Arcturus Therapeutics Holdings Inc. Recent Development

11.11 Orpharma Pty Ltd.

11.11.1 Orpharma Pty Ltd. Company Detail

11.11.2 Orpharma Pty Ltd. Business Overview

11.11.3 Orpharma Pty Ltd. Urea Cycle Disorders Treatment Drug Introduction

11.11.4 Orpharma Pty Ltd. Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024)

11.11.5 Orpharma Pty Ltd. Recent Development

11.12 Selecta Biosciences, Inc.

11.12.1 Selecta Biosciences, Inc. Company Detail

11.12.2 Selecta Biosciences, Inc. Business Overview

11.12.3 Selecta Biosciences, Inc. Urea Cycle Disorders Treatment Drug Introduction

11.12.4 Selecta Biosciences, Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024)

11.12.5 Selecta Biosciences, Inc. Recent Development

11.13 Abbott

11.13.1 Abbott Company Detail

11.13.2 Abbott Business Overview

11.13.3 Abbott Urea Cycle Disorders Treatment Drug Introduction

11.13.4 Abbott Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024)

11.13.5 Abbott Recent Development

11.14 Mead Johnson & Company, LLC

11.14.1 Mead Johnson & Company, LLC Company Detail

11.14.2 Mead Johnson & Company, LLC Business Overview

11.14.3 Mead Johnson & Company, LLC Urea Cycle Disorders Treatment Drug Introduction

11.14.4 Mead Johnson & Company, LLC Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024)

11.14.5 Mead Johnson & Company, LLC Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Horizon Therapeutics plc

Bausch Health Companies Inc.

Recordati Rare Diseases Inc.

Nestle S A

Danone

Lucane Pharma SA

Acer Therapeutics Inc.

Ultragenyx Pharmaceutical

Arcturus Therapeutics Holdings Inc.

Orpharma

Selecta Biosciences Inc

Abbott

Mead Johnson & Company, LLC

Aeglea Biotherapeutics, Inc

List of Tables

Table 1. Global Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Amino Acid Supplements

Table 3. Key Players of Sodium Phenylbutyrate

Table 4. Key Players of Glycerol Phenylbutyrate

Table 5. Key Players of Sodium Benzoate

Table 6. Key Players of Others

Table 7. Global Urea Cycle Disorders Treatment Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Urea Cycle Disorders Treatment Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Urea Cycle Disorders Treatment Drug Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Urea Cycle Disorders Treatment Drug Market Share by Region (2019-2024)

Table 11. Global Urea Cycle Disorders Treatment Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Urea Cycle Disorders Treatment Drug Market Share by Region (2025-2030)

Table 13. Urea Cycle Disorders Treatment Drug Market Trends

Table 14. Urea Cycle Disorders Treatment Drug Market Drivers

Table 15. Urea Cycle Disorders Treatment Drug Market Challenges

Table 16. Urea Cycle Disorders Treatment Drug Market Restraints

Table 17. Global Urea Cycle Disorders Treatment Drug Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Urea Cycle Disorders Treatment Drug Market Share by Players (2019-2024)

Table 19. Global Top Urea Cycle Disorders Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urea Cycle Disorders Treatment Drug as of 2023)

Table 20. Ranking of Global Top Urea Cycle Disorders Treatment Drug Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Urea Cycle Disorders Treatment Drug Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Urea Cycle Disorders Treatment Drug Product Solution and Service

Table 24. Date of Enter into Urea Cycle Disorders Treatment Drug Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Urea Cycle Disorders Treatment Drug Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Urea Cycle Disorders Treatment Drug Revenue Market Share by Type (2019-2024)

Table 28. Global Urea Cycle Disorders Treatment Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Urea Cycle Disorders Treatment Drug Revenue Market Share by Type (2025-2030)

Table 30. Global Urea Cycle Disorders Treatment Drug Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Urea Cycle Disorders Treatment Drug Revenue Market Share by Application (2019-2024)

Table 32. Global Urea Cycle Disorders Treatment Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Urea Cycle Disorders Treatment Drug Revenue Market Share by Application (2025-2030)

Table 34. North America Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Urea Cycle Disorders Treatment Drug Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Urea Cycle Disorders Treatment Drug Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Urea Cycle Disorders Treatment Drug Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Urea Cycle Disorders Treatment Drug Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Urea Cycle Disorders Treatment Drug Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Urea Cycle Disorders Treatment Drug Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size by Country (2025-2030) & (US$ Million)

Table 49. Horizon Therapeutics Plc Company Detail

Table 50. Horizon Therapeutics Plc Business Overview

Table 51. Horizon Therapeutics Plc Urea Cycle Disorders Treatment Drug Product

Table 52. Horizon Therapeutics Plc Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024) & (US$ Million)

Table 53. Horizon Therapeutics Plc Recent Development

Table 54. Bausch Health Companies Inc. Company Detail

Table 55. Bausch Health Companies Inc. Business Overview

Table 56. Bausch Health Companies Inc. Urea Cycle Disorders Treatment Drug Product

Table 57. Bausch Health Companies Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024) & (US$ Million)

Table 58. Bausch Health Companies Inc. Recent Development

Table 59. Recordati Rare Diseases Inc. Company Detail

Table 60. Recordati Rare Diseases Inc. Business Overview

Table 61. Recordati Rare Diseases Inc. Urea Cycle Disorders Treatment Drug Product

Table 62. Recordati Rare Diseases Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024) & (US$ Million)

Table 63. Recordati Rare Diseases Inc. Recent Development

Table 64. Nestle S.A. Company Detail

Table 65. Nestle S.A. Business Overview

Table 66. Nestle S.A. Urea Cycle Disorders Treatment Drug Product

Table 67. Nestle S.A. Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024) & (US$ Million)

Table 68. Nestle S.A. Recent Development

Table 69. Danone S.A. Company Detail

Table 70. Danone S.A. Business Overview

Table 71. Danone S.A. Urea Cycle Disorders Treatment Drug Product

Table 72. Danone S.A. Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024) & (US$ Million)

Table 73. Danone S.A. Recent Development

Table 74. Lucane Pharma SA Company Detail

Table 75. Lucane Pharma SA Business Overview

Table 76. Lucane Pharma SA Urea Cycle Disorders Treatment Drug Product

Table 77. Lucane Pharma SA Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024) & (US$ Million)

Table 78. Lucane Pharma SA Recent Development

Table 79. Acer Therapeutics Inc. Company Detail

Table 80. Acer Therapeutics Inc. Business Overview

Table 81. Acer Therapeutics Inc. Urea Cycle Disorders Treatment Drug Product

Table 82. Acer Therapeutics Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024) & (US$ Million)

Table 83. Acer Therapeutics Inc. Recent Development

Table 84. Ultragenyx Pharmaceutical Company Detail

Table 85. Ultragenyx Pharmaceutical Business Overview

Table 86. Ultragenyx Pharmaceutical Urea Cycle Disorders Treatment Drug Product

Table 87. Ultragenyx Pharmaceutical Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024) & (US$ Million)

Table 88. Ultragenyx Pharmaceutical Recent Development

Table 89. Aeglea Biotherapeutics, Inc Company Detail

Table 90. Aeglea Biotherapeutics, Inc Business Overview

Table 91. Aeglea Biotherapeutics, Inc Urea Cycle Disorders Treatment Drug Product

Table 92. Aeglea Biotherapeutics, Inc Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024) & (US$ Million)

Table 93. Aeglea Biotherapeutics, Inc Recent Development

Table 94. Arcturus Therapeutics Holdings Inc. Company Detail

Table 95. Arcturus Therapeutics Holdings Inc. Business Overview

Table 96. Arcturus Therapeutics Holdings Inc. Urea Cycle Disorders Treatment Drug Product

Table 97. Arcturus Therapeutics Holdings Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024) & (US$ Million)

Table 98. Arcturus Therapeutics Holdings Inc. Recent Development

Table 99. Orpharma Pty Ltd. Company Detail

Table 100. Orpharma Pty Ltd. Business Overview

Table 101. Orpharma Pty Ltd. Urea Cycle Disorders Treatment Drug Product

Table 102. Orpharma Pty Ltd. Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024) & (US$ Million)

Table 103. Orpharma Pty Ltd. Recent Development

Table 104. Selecta Biosciences, Inc. Company Detail

Table 105. Selecta Biosciences, Inc. Business Overview

Table 106. Selecta Biosciences, Inc. Urea Cycle Disorders Treatment Drug Product

Table 107. Selecta Biosciences, Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024) & (US$ Million)

Table 108. Selecta Biosciences, Inc. Recent Development

Table 109. Abbott Company Detail

Table 110. Abbott Business Overview

Table 111. Abbott Urea Cycle Disorders Treatment Drug Product

Table 112. Abbott Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024) & (US$ Million)

Table 113. Abbott Recent Development

Table 114. Mead Johnson & Company, LLC Company Detail

Table 115. Mead Johnson & Company, LLC Business Overview

Table 116. Mead Johnson & Company, LLC Urea Cycle Disorders Treatment Drug Product

Table 117. Mead Johnson & Company, LLC Revenue in Urea Cycle Disorders Treatment Drug Business (2019-2024) & (US$ Million)

Table 118. Mead Johnson & Company, LLC Recent Development

Table 119. Research Programs/Design for This Report

Table 120. Key Data Information from Secondary Sources

Table 121. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Urea Cycle Disorders Treatment Drug Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Urea Cycle Disorders Treatment Drug Market Share by Type: 2023 VS 2030

Figure 3. Amino Acid Supplements Features

Figure 4. Sodium Phenylbutyrate Features

Figure 5. Glycerol Phenylbutyrate Features

Figure 6. Sodium Benzoate Features

Figure 7. Others Features

Figure 8. Global Urea Cycle Disorders Treatment Drug Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Urea Cycle Disorders Treatment Drug Market Share by Application: 2023 VS 2030

Figure 10. Hospital Case Studies

Figure 11. Clinic Case Studies

Figure 12. Others Case Studies

Figure 13. Urea Cycle Disorders Treatment Drug Report Years Considered

Figure 14. Global Urea Cycle Disorders Treatment Drug Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Urea Cycle Disorders Treatment Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Urea Cycle Disorders Treatment Drug Market Share by Region: 2023 VS 2030

Figure 17. Global Urea Cycle Disorders Treatment Drug Market Share by Players in 2023

Figure 18. Global Top Urea Cycle Disorders Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urea Cycle Disorders Treatment Drug as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Urea Cycle Disorders Treatment Drug Revenue in 2023

Figure 20. North America Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Urea Cycle Disorders Treatment Drug Market Share by Country (2019-2030)

Figure 22. United States Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Urea Cycle Disorders Treatment Drug Market Share by Country (2019-2030)

Figure 26. Germany Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Urea Cycle Disorders Treatment Drug Market Share by Region (2019-2030)

Figure 34. China Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Urea Cycle Disorders Treatment Drug Market Share by Country (2019-2030)

Figure 42. Mexico Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Urea Cycle Disorders Treatment Drug Market Share by Country (2019-2030)

Figure 46. Turkey Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Horizon Therapeutics Plc Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2019-2024)

Figure 49. Bausch Health Companies Inc. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2019-2024)

Figure 50. Recordati Rare Diseases Inc. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2019-2024)

Figure 51. Nestle S.A. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2019-2024)

Figure 52. Danone S.A. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2019-2024)

Figure 53. Lucane Pharma SA Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2019-2024)

Figure 54. Acer Therapeutics Inc. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2019-2024)

Figure 55. Ultragenyx Pharmaceutical Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2019-2024)

Figure 56. Aeglea Biotherapeutics, Inc Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2019-2024)

Figure 57. Arcturus Therapeutics Holdings Inc. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2019-2024)

Figure 58. Orpharma Pty Ltd. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2019-2024)

Figure 59. Selecta Biosciences, Inc. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2019-2024)

Figure 60. Abbott Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2019-2024)

Figure 61. Mead Johnson & Company, LLC Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2019-2024)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-9W14014

Mon Nov 11 00:00:00 UTC 2024

Add to Cart

Treating Localized Stretch Marks - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-14S14078

Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Cloud based Solutions for Drug Discovery Development and Manufacturing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-14N13847

Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Cryopreserved Animal Hepatocytes - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-39Y14310

Thu Oct 17 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Urea Cycle Disorders Treatment Drug Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-20G14329

Global Urea Cycle Disorders Treatment Drug Market Research Report 2024

FEATURED COMPANIES

Urea Cycle Disorders Treatment Drug Market Size

Urea Cycle Disorders Treatment Drug Market

Report Scope

Scope of Urea Cycle Disorders Treatment Drug Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Urea Cycle Disorders Treatment Drug Market report?

What are the Application segmentation covered in the Urea Cycle Disorders Treatment Drug Market report?

What are the Type segmentation covered in the Urea Cycle Disorders Treatment Drug Market report?

FEATURED COMPANIES

RELATED REPORTS